CD8A and neoplasm: It was observed that the administration of immunotherapeutic inhibitors (ICIs) in combination with early steroidal treatment, but not late, resulted in the weakening of antitumor activity, promoting tumor regrowth and a reduction in CD8+ T cell proliferation.